Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
210 At the time of writing, the Pharmaceutical Benefits Advisory Committee has made a positive recommendation for semaglutide in a subgroup of people with obesity and established CVD
Pick your vial, set your dose, see the exact units to draw with a visual syringe so you don't have to squint at tick marks
The recorded data also helps refine future delivery methods, ensuring an ongoing commitment to quality
You may be a candidate if you: Struggle with weight loss despite diet and exercise Experience frequent hunger or cravings Prefer a non-surgical weight loss solution Are committed to making long-term lifestyle changes A consultation at Amerejuve MedSpa is required to determine eligibility and ensure optimal outcomes
Eli Lilly also offers savings programs to help with the expense
US$ 21.42
US$ 29.23
US$ 27.08
